What is HemaSource?
Headquartered in West Jordan, Utah, HemaSource Intermediate Holdings, LLC operates as a technology-enabled distributor specializing in the plasma collection market. The company manages an extensive portfolio of 1,300 SKUs, supported by two strategically positioned distribution centers that ensure seamless delivery of essential medical consumables. Beyond traditional distribution, HemaSource distinguishes itself through a proprietary cloud-based inventory management and business intelligence platform. This software suite empowers plasma collection centers to achieve superior supply chain efficiencies, directly reducing operational costs while ensuring the steady availability of plasma-derived therapeutics such as IVIG, Albumin, and Factor VIII. These products are fundamental to treating complex conditions, including immunodeficiency diseases and various hematology disorders, positioning HemaSource as a vital link in the global healthcare infrastructure.
How much funding has HemaSource raised?
HemaSource has raised a total of $13.5M across 1 funding round:
Private Equity
$13.5M
Private Equity (2010): $13.5M, investors not publicly disclosed
Key Investors in HemaSource
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for HemaSource?
With this major strategic investment, HemaSource is well-positioned to scale its technological infrastructure and expand its distribution footprint. The company's focus on integrating advanced business intelligence into the plasma supply chain suggests a future roadmap centered on digital transformation and operational excellence. As the demand for plasma-derived therapies continues to rise globally, HemaSource's ability to provide data-driven supply chain solutions will likely serve as a key competitive advantage. Future initiatives will likely involve enhancing their cloud-based software capabilities and potentially broadening their SKU offerings to address emerging needs within the hematology and immunology sectors, ensuring sustained long-term value for stakeholders and healthcare providers alike.
See full HemaSource company page
